A J Kazimi bought $1,755 of CPIX
Chairman and CEO at CUMBERLAND PHARMACEUTICALS INC. 1,506 shares at an average of $1.17, traded Nov 1, 2024, filed Dec 5, 2024.
Score components
- +25RoleCEO
- 0Trade size$2k at market
- -5Relative to holdingsUnder 1% of holdings (0.0%)
- 0Price contextNo price history yet
- +15Cluster4 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -1510b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-24-050107, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 1, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.15 | $87 | 5,700,097 | Dec 5, 2024 |
| Nov 4, 2024 | POpen-market purchase Common Stock10b5-1 | +49 | $1.17 | $57 | 5,700,146 | Dec 5, 2024 |
| Nov 5, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.20 | $91 | 5,700,222 | Dec 5, 2024 |
| Nov 6, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.20 | $91 | 5,700,298 | Dec 5, 2024 |
| Nov 7, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.17 | $89 | 5,700,374 | Dec 5, 2024 |
| Nov 8, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.18 | $90 | 5,700,450 | Dec 5, 2024 |
| Nov 11, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.20 | $91 | 5,700,526 | Dec 5, 2024 |
| Nov 12, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.20 | $91 | 5,700,602 | Dec 5, 2024 |
| Nov 13, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.20 | $91 | 5,700,678 | Dec 5, 2024 |
| Nov 14, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.19 | $90 | 5,700,754 | Dec 5, 2024 |
| Nov 15, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.17 | $89 | 5,700,830 | Dec 5, 2024 |
| Nov 18, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.18 | $90 | 5,700,906 | Dec 5, 2024 |
| Nov 19, 2024 | POpen-market purchase Common Stock10b5-1 | +76 | $1.15 | $87 | 5,700,982 | Dec 5, 2024 |
| Nov 20, 2024 | POpen-market purchase Common Stock10b5-1 | +85 | $1.13 | $96 | 5,701,067 | Dec 5, 2024 |
| Nov 21, 2024 | POpen-market purchase Common Stock10b5-1 | +85 | $1.09 | $93 | 5,701,152 | Dec 5, 2024 |
| Nov 22, 2024 | POpen-market purchase Common Stock10b5-1 | +75 | $1.07 | $80 | 5,701,227 | Dec 5, 2024 |
| Nov 25, 2024 | POpen-market purchase Common Stock10b5-1 | +75 | $1.09 | $82 | 5,701,302 | Dec 5, 2024 |
| Nov 26, 2024 | POpen-market purchase Common Stock10b5-1 | +75 | $1.11 | $83 | 5,701,377 | Dec 5, 2024 |
| Nov 27, 2024 | POpen-market purchase Common Stock10b5-1 | +75 | $1.15 | $86 | 5,701,452 | Dec 5, 2024 |
| Nov 29, 2024 | POpen-market purchase Common Stock10b5-1 | +75 | $1.32 | $99 | 5,701,527 | Dec 5, 2024 |
Related signals
Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Kenneth Krogulski director | $8,209 | 4,716 | |
| 25Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | A J Kazimi Chairman and CEO | $1,318 | 769 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | James Jones director | $1,318 | 769 | |
| 15Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Caroline Young director | $256 | 154 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Kenneth Krogulski director | $9,348 | 8,029 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | James Jones director | $1,755 | 1,506 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Caroline Young director | $755 | 647 | |
| 15Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | Kenneth Krogulski director | $9,106 | 7,107 | |
| 20Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | A J Kazimi Chairman and CEO | $1,827 | 1,426 | |
| 15Weak | buy 410b5-1 | CPIX CUMBERLAND PHARMACEUTICALS INC | James Jones director | $1,827 | 1,426 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.